Article
  • The Effects of Osmogant and Binder in Membrane on Nifedipine Release from Osmotic Granule
  • Jeong SC, Cho YH, Kim MS, Lee B, Khang G, Rhee JM, Lee HB
  • 니페디핀의 삼투성 과립에서 삼투염과 반투막내의 결합제 종류가 약물방출에 미치는 영향
  • 정성찬, 조영호, 김문석, 이봉, 강길선, 이종문, 이해방
References
  • 1. Perkins L, Peer C, Fleming VPumps/osmotic-alzet system, in Encyclopedia of Controlled Drug Delivery, E. Mathiowitz, Ed., Wiley, New York, U.S.A, 2, 900 (1999)
  •  
  • 2. Magruder JPumps/osmotic-VITS veterinary implant, in Encyclopedia of Controlled Drug Delivery, E. Mathiowitz, Ed., Wiley, New York, U.S.A, 2, 906 (1999)
  •  
  • 3. Wright JC, Stevenson CL, Stewart GRPumps/osmotic-DUROS osmotic implant for humans, in Encyclopedia of Controlled Drug Delivery, E. Mathiowitz, Ed., Wiley, New York, U.S.A, 2, 909 (1999)
  •  
  • 4. Wright JPumps/osmotic-ruminal osmotic bolus, in Encyclopedia of Controlled Drug Delivery, E. Mathiowitz, Ed., Wiley, New York, U.S.A, 2, 915 (1999)
  •  
  • 5. Theeuwes F, Wong PSL, Burkoth TL, Fox DAOsmotic systems for colon-targeted drug delivery, in Colonic Drug Absorption and Metabolism, P.R. Bieck, Ed., Marcel Dekker, New York, U.S.A, 137 (1993)
  •  
  • 6. Amkraut A, Eckenhoff JB, Nichols K, Adv. Drug Deliv. Rev., 4, 255 (1990)
  •  
  • 7. Theeuwes F, J. Pharm. Sci., 64, 1987 (1975)
  •  
  • 8. Wong PSL, Barclay BL, Deters JC, TheeuwesU.S. Patent 4,765,989 (1986)
  •  
  • 9. Theeuwes F, Pharm. Int., 5, 293 (1984)
  •  
  • 10. Theeuwes FNovel Drug Delivery Systems, ADIS Press, 157 (1981)
  •  
  • 11. Kage H, Abe R, Hattanda R, Zhou T, Ogura H, Matsuno Y, Powder Technol., 130(1-3), 203 (2003)
  •  
  • 12. Deast PBMicroencapsulation and Related Drug Processes, Marcel Dekker, New York (1984)
  •  
  • 13. Liu L, Khang G, Rhee JM, Lee HB, Polym.(Korea), 7, 289 (1999)
  •  
  • 14. Liu L, Khang G, Rhee JM, Lee HB, Biomater. Res, 3, 47 (1999)
  •  
  • 15. Liu L, Khang G, Rhee JM, Lee HB, Bio-Med. Mater. Eng., 9, 297 (1999)
  •  
  • 16. Liu L, Khang G, Rhee JM, Lee HB, J. Control. Release, 67, 309 (2000)
  •  
  • 17. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB, J. Control. Release, 68, 145 (2000)
  •  
  • 18. Khang G, Ku J, Lee B, Lee HB, Biomater. Res., 4, 20 (2000)
  •  
  • 19. Lui L, Khang G, Rhee JM, Lee HB, Acta Pharmacol. Sin., 38, 620 (2003)
  •  
  • 20. Lui L, Xu Q, Khang G, Rhee JM, Lee HB, Acta Pharmacol. Sin., 38, 966 (2003)
  •  
  • 21. Sudsakorn K, Turton R, Powder Technol., 110(1-2), 37 (2000)
  •  
  • 22. Kage H, Abe R, Hattanda R, Zhou T, Ogura H, Matsuno Y, Powder Technol., 130(1-3), 203 (2003)
  •  
  • 23. Donbrow MMicroencapsulation and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL (1991)
  •  
  • 24. Ho H, Chen C, Sheu M, J. Control. Release, 68, 433 (2000)
  •  
  • 25. Wang Y, Winnik MA, Macromolecules, 23, 4731 (1990)
  •  
  • 26. Siepmann J, Lecomte F, Bodmeirer R, J. Control. Release, 60, 379 (1999)
  •  
  • 27. Jeong SC, Chon SK, Jo YH, Kim MS, Lee B, Khang G, Lee HB, Polym.(Korea), 29(3), 288 (2005)
  •  
  • 28. Colombo P, Bettimi R, Massimo G, Catellani PL, Santi P, Peppas NA, J. Pharm. Sci., 84, 991 (1995)
  •  
  • 29. Rowe RC, Int. J. Pharm., 29, 37 (1986)
  •  
  • 30. Wade A, Weller PJHandbook of Pharmaceutical Excipients, Am. Pharm. Assoc., Washington DC (1994)
  •  
  • 31. Harris MR, Ghebre-Sellassie I, Nesbitt RU, Pharm. Technol., 10, 102 (1986)
  •  
  • 32. Meier MM, Kanis LA, Soldi V, Int. J. Pharm., 278, 99 (2004)
  •  
  • 33. Auda HSA, Najjar TA, Al-Khamis KI, AI-Hadiya BM, Ghilzai NM, AI-Fawzan NF, J. Pharm. Biomed. Anal., 22, 241 (2000)
  •  
  • 34. Niopas I, Dafrsios AC, J. Pharm. Biomed. Anal., 32, 1213 (2003)
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 0379-153X(Print)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2023 Impact Factor : 0.4
  • Indexed in SCIE

This Article

  • 2006; 30(2): 112-117

    Published online Mar 25, 2006

  • 10.7317/pk.
  • Received on Aug 5, 2005
  • Revised on Nov 30, -0001
  • Accepted on Mar 13, 2006

Correspondence to

  • E-mail: